REGULATORY

• Public Knowledge-Based Application OK’ed for Endoxan Label Expansion
  June 2, 2023

• SaMD Could Be Eligible for 2-Stage Approval System: MHLW
  June 1, 2023

• Japan Diet Enacts Bill to Create “Japan CDC”
  June 1, 2023

• Japan to Quadruple Supplies of Sublingual Hay Fever Therapy in 5 Years
  May 31, 2023

• LDP OKs Project Team Proposal to Boost Pharma Innovation, Create Command Tower
  May 31, 2023

• LDP Launches Lawmakers’ League on Self-Medication
  May 31, 2023

• Japan to Launch New Forum to Spur Secondary Use of Medical Data in Drug Discovery
  May 30, 2023

• Japan Trade Minister Demands China Release Detained Astellas Employee
  May 30, 2023

• MOF Panel Flags Japan’s High Drug Cost per Capita, Stays Pat on Cost-Effectiveness-Based Reimbursement, Copay Review
  May 30, 2023

• Cancer Meds from Servier, Taiho, Pfizer’s AA Drug Clear Review for June Approval
  May 30, 2023

• PM Advisors Make Irregular Call for Properly Rewarding Innovation to Boost Japan’s Drug Discovery Capabilities
  May 29, 2023

• Gene Therapy Luxturna Now in Line for Approval in June
  May 29, 2023

• Relief Claims OK’ed for 14 More Deaths Possibly Tied to COVID Jabs
  May 29, 2023

• Japan Approves Label Expansions for Ultomiris, Skyrizi, Vanflyta
  May 26, 2023

• Expert Panel Meeting Canceled Due to Lack of Coordination: MHLW Official
  May 26, 2023

• Expedite Introduction of High-Priority Vaccines into National Schedule: Trade Groups
  May 25, 2023

• Orphan Tag Granted to Opdivo, Leniolisib, and 6 More APIs
  May 24, 2023

• LDP Pharma Study Group Proposes Removing Cap for Social Security Costs
  May 23, 2023

• Ophthalmic Mitomycin, OD Tablets for Takecab and Tarlige to Get Listing on May 24
  May 23, 2023

• MHLW Cancels Expert Panel Meeting on May 23, Report Delayed
  May 23, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 88
• 89
• 90
• 91
• 92
• 93
• 94
• 95
• 96
• …
• Next ›
• 最終 »